Capex / revenue moved 237 bp higher
Capex / revenue changed +237 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed +237 basis points from the comparable as-filed period.
Gross margin changed +129 basis points from the comparable as-filed period.
Operating cash flow changed +13.5% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Gross profit changed +21.6% from the comparable as-filed period.
Inventory changed +16.3% from the comparable as-filed period.
Inventory / revenue changed -192 basis points from the comparable as-filed period.
Selling, general & administrative changed +18.1% from the comparable as-filed period.
Stock-based compensation changed +22.7% from the comparable as-filed period.
SBC / revenue changed +3 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.